{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T02:48:38Z","timestamp":1769568518599,"version":"3.49.0"},"reference-count":5,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>This case report presents a woman with post-partum depression treated with cabergoline for lactation inhibition who developed psychotic symptoms. She was admitted with moderate depression following a suicide attempt, and started on cabergoline and sertraline, with initial improvement of the depressive symptoms. Six days after starting cabergoline, she developed severe psychotic symptoms. Symptoms rapidly improved with antipsychotics and ECT. Due to the long half-life of cabergoline, this case potentially highlights a rare but serious adverse effect of cabergoline.<\/jats:p>","DOI":"10.61409\/v08250663","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:01:31Z","timestamp":1769072491000},"page":"1-3","source":"Crossref","is-referenced-by-count":0,"title":["Psychosis after lactation inhibition with cabergoline"],"prefix":"10.61409","author":[{"given":"Amalie Munk","family":"Eefsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid H\u00f8jmark","family":"Gimbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela Salagre","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Harris K, Murphy KE, Horn D, et al. Safety of cabergoline for postpartum lactation inhibition or suppression: a systematic review. J Obstet Gynaecol Can. 2020;42(3):308-315.e20. https:\/\/doi.org\/10.1016\/j.jogc.2019.03.014","DOI":"10.1016\/j.jogc.2019.03.014"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Snellen M, Power J, Blankley G, Galbally M. Pharmacological lactation suppression with D2 receptor agonists and risk of postpartum psychosis: a systematic review. Aust N Z J Obstet Gynaecol. 2016;56(4):336-340. https:\/\/doi.org\/10.1111\/ajo.12479","DOI":"10.1111\/ajo.12479"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Gupta P, Tundup T, Singh J, et al. Treatment complexities in psychosis associated with cabergoline treatment in patients having pituitary prolactinomas. Asian J Psychiatr. 2018;31:129-132. https:\/\/doi.org\/10.1016\/j.ajp.2018.01.011","DOI":"10.1016\/j.ajp.2018.01.011"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Y\u00fcksel RN, Elyas Kaya Z, Dilbaz N, Cingi Yir\u00fcn M. Cabergoline-induced manic episode: case report. Ther Adv Psychopharmacol. 2016;6(3):229-231. https:\/\/doi.org\/10.1177\/2045125315626345","DOI":"10.1177\/2045125315626345"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Bilal L, Ching C. Cabergoline-induced psychosis in a patient with undiagnosed depression. J Neuropsychiatry Clin Neurosci. 2012;24(4):E54. https:\/\/doi.org\/10.1176\/appi.neuropsych.11110348","DOI":"10.1176\/appi.neuropsych.11110348"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:58:30Z","timestamp":1769522310000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V08250663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":5,"URL":"https:\/\/doi.org\/10.61409\/v08250663","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}